Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
405.00
-8.48 (-2.05%)
At close: Apr 17, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $328.32 billion as of April 17, 2026. Its market cap has increased by 21.66% in one year.
Market Cap
328.32B
Enterprise Value
356.28B
Revenue
79.90B
Ranking
n/a
PE Ratio
20.21
Stock Price
$405.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 328.32B, an increase of 3,648.50%. That is a compound annual growth rate of 11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 328.32B | -0.97% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 785.78M |
| Veradigm | 732.77M |
| Glass House Brands | 695.27M |
| CytoDyn | 503.38M |
| Elite Pharmaceuticals | 417.34M |
| Silence Therapeutics | 358.98M |
| Northwest Biotherapeutics | 325.52M |
| American Oncology Network | 246.25M |